Omega Fund Management as of March 31, 2026
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 10 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bicara Therapeutics Common Stock (BCAX) | 29.2 | $48M | 2.4M | 19.89 | |
| Nuvation Bio Common Stock Class A (NUVB) | 21.2 | $35M | 8.1M | 4.29 | |
| BridgeBio Oncology Therapeutics Common Stock (BBOT) | 18.0 | $29M | 3.3M | 8.95 | |
| Kestra Med Technologies Common Stock (KMTS) | 12.5 | $20M | 1.0M | 19.93 | |
| Beta Bionics Common Stock (BBNX) | 8.1 | $13M | 1.3M | 10.02 | |
| enGene Holdings Common Stock | 3.7 | $6.0M | 876k | 6.81 | |
| Alumis Common Stock (ALMS) | 3.3 | $5.3M | 241k | 22.03 | |
| Sana Biotechnology Common Stock (SANA) | 1.5 | $2.4M | 844k | 2.88 | |
| ImageneBio Common Stock (IMA) | 1.4 | $2.3M | 455k | 5.00 | |
| Replimune Group Common Stock (REPL) | 1.2 | $1.9M | 249k | 7.68 |
